Literature DB >> 23023845

Dietary approaches to hypertension: a call to pharmacists to promote lifestyle changes.

Grace L Earl1, Jule Anne Henstenburg.   

Abstract

OBJECTIVES: To describe guideline updates regarding a dietary approach to preventing or treating hypertension and to encourage pharmacists to provide education to patients on the Dietary Approaches to Stop Hypertension (DASH) diet and reducing dietary sodium intake. DATA SOURCES: Abstracts and published articles identified by searching Medline (January 2001 to July 2011) and International Pharmaceutical Abstracts (January 2001 to July 2011) using the terms hypertension, cardiovascular risk, risk reduction behavior, health behavior, community pharmacy services, counseling, diet, and sodium-restricted diet, as well as reports from the Institute of Medicine and Dietary Guidelines for Americans 2010. DATA SYNTHESIS: In the Dietary Guidelines for Americans 2010, the recommended daily dietary sodium intakes for individuals with hypertension, chronic kidney disease, and diabetes was reduced to less than 1,500 mg per day. All other healthy individuals are recommended to achieve dietary sodium intakes of less than 2,300 mg per day. Americans are consuming excessive amounts of dietary sodium in the form of processed foods, which poses a barrier to blood pressure control. Pharmacists should recommend the DASH diet as a way to reduce intake of dietary sodium and use available nutrition resources found on the ChooseMyPlate.gov and Food and Drug Administration websites. Pharmacists should integrate approaches using behavioral and motivational strategies to provide education that is culturally sensitive and appeals to individuals with marginal health literacy.
CONCLUSION: Community and ambulatory practice pharmacists, as well as collaborative practice models between pharmacists and physicians, should optimize medication management and incorporate lifestyle interventions that reduce dietary sodium intake as part of a comprehensive approach to improve hypertension outcomes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23023845     DOI: 10.1331/JAPhA.2012.10241

Source DB:  PubMed          Journal:  J Am Pharm Assoc (2003)        ISSN: 1086-5802


  4 in total

1.  The influence of multidisciplinary team clinic on the prognosis of patients with chronic kidney disease.

Authors:  Zhixiang Bian; Qin Zhang; Li Shen; Shunjie Chen
Journal:  Exp Biol Med (Maywood)       Date:  2022-02-24

2.  Phosphate-Induced Renal Fibrosis Requires the Prolyl Isomerase Pin1.

Authors:  Zhong-Jian Shen; Jie Hu; Kazuhiro Shiizaki; Makoto Kuro-o; James S Malter
Journal:  PLoS One       Date:  2016-02-25       Impact factor: 3.240

3.  The multiple lifestyle modification for patients with prehypertension and hypertension patients: a systematic review protocol.

Authors:  Juan Li; Hui Zheng; Huai-bin Du; Xiao-ping Tian; Yi-jing Jiang; Shao-lan Zhang; Yu Kang; Xiang Li; Jie Chen; Chao Lu; Zhen-hong Lai; Fan-rong Liang
Journal:  BMJ Open       Date:  2014-08-14       Impact factor: 2.692

4.  Consumer's Opinion on a Pharmacist's Role in Nutritional Counseling.

Authors:  Megan Meier; Reshmi L Singh; Baskaran Thyagarajan
Journal:  Innov Pharm       Date:  2021-04-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.